Chiron Capital Management’s AB InBev BUD Stock Holding History

Chiron Capital Management’s Portfolio BUD Stock Details BUD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-24,870	Closed	-$1.38M	–	119
2023 Q3	$1.38M	Sell	24,870 -1,200	-5%	-$68K	1.18%	16
2023 Q2	$1.48M	Sell	26,070 -6,000	-19%	-$363K	1.17%	13
2023 Q1	$2.14M	Sell	32,070 -6,300	-16%	-$381K	1.49%	6
2022 Q4	$2.3M	Sell	38,370 -2,300	-6%	-$124K	1.6%	7
2022 Q3	$1.84M	Buy	40,670 +275	+0.7%	+$14.2K	1.23%	8
2022 Q2	$2.18M	Buy	40,395 +8,700	+27%	+$489K	1.37%	9
2022 Q1	$1.9M	Buy	31,695 +3,100	+11%	+$191K	1.2%	11
2021 Q4	$1.73M	Sell	28,595 -5,100	-15%	-$297K	1.25%	13
2021 Q3	$1.9M	Buy	33,695 +11,635	+53%	+$730K	1.39%	9
2021 Q2	$1.59M	Sell	22,060 -12,110	-35%	-$883K	1.32%	14
2021 Q1	$2.15M	Buy	34,170 +9,279	+37%	+$599K	1.82%	9
2020 Q4	$1.74M	Sell	24,891 -6,439	-21%	-$407K	1.43%	12
2020 Q3	$1.69M	Buy	+31,330	New	+$1.74M	1.36%	9

Other funds holding BUD

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Gates Foundation Trust Kirkland, Washington $34.4B AUM 26.34% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Chiron Capital Management's BUD Position: Q4 2023 in Review

Chiron Capital Management sold out of AB InBev (BUD) in Q4 2023, closing a stake of 24,870 shares — an estimated $1.38M sold.

Chiron Capital Management first reported a position in BUD in Q3 2020 and held it in 13 quarters. The position peaked at $2.3M in Q4 2022. 514 funds tracked by Wall St. Rank hold BUD as of Q4 2023.

Chiron Capital Management reported no remaining AB InBev position as of Q4 2023 after selling out during the quarter.
Chiron Capital Management sold 24,870 AB InBev shares in Q4 2023, an estimated $1.38M.
Chiron Capital Management first reported a position in AB InBev in Q3 2020 and held it in 13 quarters.
Chiron Capital Management's AB InBev position peaked at $2.3M in Q4 2022.
514 funds tracked by Wall St. Rank held AB InBev as of Q4 2023.

Based on Chiron Capital Management's 13F filing for Q4 2023, filed 12 Feb 2024.